SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Costco Wholesale Corp. engages in the provision of operation of membership warehouses through wholly owned subsidiaries. It operates through the following geographical segments: United States, Canada, and Other International Operations. The company was founded by James D. Sinegal and Jeffrey H. Brotman in 1983 and is headquartered in Issaquah, WA.

Costco Wholesale Corp

Costco is currently trending as investors monitor its resilience amid macroeconomic volatility and ongoing debates surrounding the impact of potential tariff refunds on retail pricing. The community remains focused on Costco's defensive strengths, with frequent discussions centered on its robust membership renewal rates, traffic growth, and valuation relative to the broader consumer staples sector.

Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Wayne, PA.

Avalo Therapeutics Inc

Avalo Therapeutics is generating significant investor interest driven by high trading volumes, active momentum in its clinical-stage pipeline, and multiple analyst endorsements from firms like Guggenheim and HC Wainwright. Community discussion is focused on the high-stakes Phase 2 LOTUS trial readout expected in 2026 and ongoing debates regarding the company's financial risk profile versus the potential upside of its immunology platform.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is currently a focal point for the community due to renewed institutional interest, shifting ecosystem management, and ongoing discussions regarding its quantum-resistant technology. While some traders debate the asset's long-term viability following historic price volatility, active participants are heavily focused on potential regulatory catalysts and the ongoing expansion of its real-world asset (RWA) utility.

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF is capturing investor attention as they rotate toward defensive, value-oriented positions amidst broader market volatility. The community is actively debating the fund's resilience, with many investors maintaining a long-term 'buy and hold' strategy despite recent stagnant performance, while others monitor the ETF's sector diversification and dividend growth potential as a reliable hedge.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending as the community speculates on a major upcoming partnership announcement, with many pointing to a connection with Stellar or a potential collaboration with Ripple/XRP at an upcoming industry event. Investors are actively debating the project's long-term utility in global payroll and real-world adoption, balancing high-conviction sentiment against skepticism regarding its price performance and market volatility.

Arista Networks, Inc. engages in the development, marketing, and sale of cloud networking solutions. Its solutions include EOS, a set of network applications, and Gigabit Ethernet switching and routing platforms. Its product categories include Core, Cognitive Adjacencies, and Network Software and Services. The company was founded by Andreas Bechtolsheim, David Cheriton, and Kenneth Duda in November 2004 and is headquartered in Santa Clara, CA.

Arista Networks Inc

Arista Networks is currently navigating volatility as investors react to a strong quarterly earnings report that featured double-beat results and raised guidance, yet faced downward pressure from cautious forward-looking commentary. The community is actively debating whether this pullback represents an attractive buying opportunity for long-term growth in the high-performance AI networking sector or if current valuation concerns will keep the stock range-bound.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as the market evaluates its evolving oncology pipeline and potential expansion into weight-loss treatments following recent positive study results. While some investors are bullish on the company's defensive positioning and dividend stability, others remain focused on headwinds related to patent cliffs and mixed sentiment regarding the company's vaccine portfolio.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP is trending as the community debates its long-term viability, with supporters pointing to upcoming regulatory clarity like the Clarity Act and existing infrastructure partnerships, while skeptics emphasize a prolonged downward price trend and lack of active communication from project leadership.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly is a primary focal point of market discourse following the FDA approval of Foundayo, its once-daily oral GLP-1 weight-loss pill, which analysts view as a major step toward expanding the obesity treatment market through improved convenience and scalability. While community discussion remains intense regarding its competitive positioning against Novo Nordisks oral offerings, the broader pharma sector is also digesting the implications of potential new pharmaceutical tariff policies and ongoing M&A activity, keeping Eli Lillys valuation and long-term growth trajectory at the center of investor focus.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BCRX is trending due to surging after-hours volume and unconfirmed speculation regarding a potential buyout, which has intensified community discussion about its valuation and long-term pipeline potential. Investors are closely monitoring unusual block trades and technical price action, viewing these signals as potential precursors to an M&A event despite historical skepticism regarding the company's independence.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

FNY Investment Advisers LLC Makes New Investment in Nucor Corporation $NUE

FNY Investment Advisers LLC acquired a new position in shares of Nucor Corporation (NYSE:NUE - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the...

<ul class="summary-bullets"><li>Century Aluminum surged 245% in the past year, far outpacing peers and benchmarks.</li><li>Steel Dynamics and Nucor rose 48% and 45%, beating the S&amp;P 500 and Nasdaq.</li><li>Cleveland-Cliffs gained just 2%, even as tariffs boosted industry demand.</li></ul>&nbsp;A year after President Donald Trump’s “Liberation Day” tariffs reshaped the U.S. metals trade, the scoreboard across steel and aluminum stocks is anything but uniform. While Century Aluminum (<a href="https://stocktwits.com/symbol/CENX">CENX</a>) has surged more than 200% and outpaced the broader market by a wide margin, peers like Steel Dynamics (<a href="https://stocktwits.com/symbol/STLD">STLD</a>) and Nucor (<a href="https://stocktwits.com/symbol/NUE">NUE</a>) posted strong gains, while Cleveland-Cliffs (<a href="https://stocktwits.com/symbol/CLF">CLF</a>) barely moved.CENX shares have surged 245%; STLD and NUE rose 48% and 45%, respectively, outperforming the S&amp;P 500, which rose 17%, and the Nasdaq, which gained 13% over the same period. Meanwhile, CLF gained 2%, underperforming the broader benchmarks.The divergence comes despite a broadly supportive policy backdrop. Three months after the initial tariff rollout, the Trump administration raised duties on steel and aluminum imports from 25% to 50%, aiming to curb imports and boost domestic production.A year since the tariff imposition, the President’s administration is reportedly preparing to outline a tiered system for its broad tariffs on steel and aluminum products. While maintaining 50% tarrifs on a large number of derivative products, many other products will be tariffed at a lower 25% rate, while some products will fall below that duty level.<h2 class="st-heading-2">Industry Players Say Tariffs Have Already Tightened Supply and Improved Order Visibility.&nbsp;</h2>&nbsp;In February, CENX said that Trump’s trade policies strengthened its commitment to reshore U.S. production of primary aluminum. Over the last year, CENX increased total U.S. primary aluminum production by almost 10% through the expansion of its smelter and plans to build a new smelter, which will double U.S. production.In its fourth-quarter report, Steel Dynamics noted that high-cost imports, driven by increased tariffs, have created a significant domestic aluminum sheet supply deficit of over 1.4 million tons, which is expected to grow along with demand.Similarly, Nucor said in its latest earnings call that it expects the full impact of tariffs and recent trade determinations to lower levels of imported steel in 2026, which is why NUE entered the year with historically strong backlogs, up nearly 40% year-over-year in the steel mills segment and 15% in steel products.Cleveland-Cliffs also reported that its robust order book is the “best confirmation” that the business environment has already begun to improve, and that the 50% tariffs are a leading driver of this impact.&nbsp;<h2 class="st-heading-2">STLD, CLF, NUE, CENX: How Have Retail Traders Reacted?</h2>&nbsp;On Stocktwits, retail sentiment toward Century Aluminum mostly remained in the ‘bullish’ range for the year, while message volumes jumped to ‘extremely high’ from ‘low’. While, sentiment towards Steel Dynamics, Nucor, and Cleveland-Cliffs mostly stayed at ‘neutral’ through the year.&nbsp;&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/lw-stock-slides-after-q3-earnings-beat-draws-retail-buzz/cZ7xl11RIFM">McDonald's Supplier Lamb Weston Posts ‘Solid’ Q3 Beat, But Stock Tumbles On Narrowed Outlook: Wall Street Still Sees Hope</a>

Donald Trump pictured in the Oval Office of the White House on November 10, 2025. (Photo by Anna Moneymaker/Getty Images)

One Year After Trump's Liberation Day Tariffs: Here's How These 4 Steel And Aluminum Stocks Fared

A year on, policymakers are now reportedly considering a tiered tariff structure, maintaining 50% duties on some products while lowering others to 25% or below.

Equity

A year on, policymakers are now reportedly considering a tiered tariff structure, maintaining 50% duties on some products while lowering others to 25% or below.


Nucor (NYSE:NUE) Earns Buy Rating from Analysts at The Goldman Sachs Group

The Goldman Sachs Group assumed coverage on Nucor in a report on Wednesday. They set a "buy" rating and a $210.00 price objective on the stock...

Meyer Handelman Co. Sells 6,870 Shares of Nucor Corporation $NUE

Meyer Handelman Co. decreased its stake in Nucor Corporation (NYSE:NUE - Free Report) by 8.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities...

Allspring Global Investments Holdings LLC Has $90.13 Million Stock Holdings in Nucor Corporation $NUE

Allspring Global Investments Holdings LLC raised its holdings in Nucor Corporation (NYSE:NUE - Free Report) by 2.5% in the fourth quarter, according to the company in its most recent Form 13F filing...

Nucor (NUE) Ascends But Remains Behind Market: Some Facts to Note

In the most recent trading session, Nucor (NUE) closed at $169.1, indicating a +2.64% shift from the previous trading day.

Ex-Div Reminder for Nucor (NUE)

Looking at the universe of stocks we cover at Dividend Channel, on 3/31/26, Nucor Corp. (Symbol: NUE) will trade ex-dividend, for its quarterly dividend of $0.56, payable on 5/11/26. As a percentage of NUE's recent stock price of $164.52, this dividend works out to approximatel...

SG Americas Securities LLC Purchases 47,235 Shares of Nucor Corporation $NUE

SG Americas Securities LLC lifted its holdings in Nucor Corporation (NYSE:NUE - Free Report) by 123.5% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 85,474 shares of the basic materials company's stock after buying a...

Dakota Wealth Management Invests $2.28 Million in Nucor Corporation $NUE

Dakota Wealth Management purchased a new stake in shares of Nucor Corporation (NYSE:NUE - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and...

Nucor (NYSE:NUE) Rating Increased to Buy at Wall Street Zen

Wall Street Zen upgraded shares of Nucor from a "hold" rating to a "buy" rating in a research report on Saturday...

Nucor Corp. engages in the manufacture of steel products, and ferrous and non-ferrous materials. It operates through the following segments: Steel Mills, Steel Products, and Raw Materials. The Steel Mills segment consists of producing sheet, plate, structural, and bar steel. The Steel Products segment includes steel joists and joist girders, deck, fabricated concrete reinforcing, cold finished, fasteners, metal building systems, grating, tubular, piling products businesses, and wire mesh. The Raw Materials segment consists of direct reduced iron, and ferrous and nonferrous metals. The company was founded by Ransom E. Olds in 1905 and is headquartered in Charlotte, NC.

Nucor Corp.

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

NUE
Nucor Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest NUE News

NUENucor Corp.